BioCardia Inc. [BCDA] stock is trading at $4.02, up 82.73%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BCDA shares have gain 48.89% over the last week, with a monthly amount glided 33.55%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
BioCardia Inc. [NASDAQ: BCDA] stock has seen the most recent analyst activity on April 16, 2021, when Dawson James downgraded its rating to a Neutral.
BioCardia Inc. [BCDA] stock has fluctuated between $1.96 and $23.25 over the past year. BioCardia Inc. [NASDAQ: BCDA] shares were valued at $4.02 at the most recent close of the market.
Analyzing the BCDA fundamentals
BioCardia Inc. [NASDAQ:BCDA] reported sales of 0.43M for the trailing twelve months, which represents a drop of -93.02%. Gross Profit Margin for this corporation currently stands at 0.02% with Operating Profit Margin at -20.05%, Pretax Profit Margin comes in at -20.0%, and Net Profit Margin reading is -20.0%. To continue investigating profitability, this company’s Return on Assets is posted at -2.96, Equity is 5.27 and Total Capital is 7.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.58.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.08 points at the first support level, and at 2.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.81, and for the 2nd resistance point, it is at 5.60.
Ratios To Look Out For
For context, BioCardia Inc.’s Current Ratio is 0.39. In addition, the Quick Ratio stands at 0.39 and the Cash Ratio stands at 0.35. Considering the valuation of this stock, the price to sales ratio is 19.82.
Transactions by insiders
Recent insider trading involved Altman Peter, President and CEO, that happened on Jul 01 ’24 when 300.0 shares were purchased. President and CEO, Altman Peter completed a deal on Jun 28 ’24 to buy 200.0 shares. Meanwhile, President and CEO Altman Peter bought 500.0 shares on Jun 21 ’24.
